Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kondylis, Athanasios"" wg kryterium: Autor


Wyświetlanie 1-15 z 15
Tytuł:
Biological changes in C57BL/6 mice following 3 weeks of inhalation exposure to cigarette smoke or e-vapor aerosols.
Autorzy:
Lee KM; a Altria Client Services LLC , Richmond , VA , USA.
Hoeng J; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Harbo S; c Battelle , Columbus , OH , USA.
Kogel U; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Gardner W; a Altria Client Services LLC , Richmond , VA , USA.
Oldham M; a Altria Client Services LLC , Richmond , VA , USA.
Benson E; c Battelle , Columbus , OH , USA.
Talikka M; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Kondylis A; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Martin F; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Titz B; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Ansari S; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Trivedi K; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Guedj E; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Elamin A; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Ivanov NV; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Vanscheeuwijck P; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
Peitsch MC; b PMI R&D, Philip Morris Products S.A , Neuchâtel , Switzerland.
McKinney WJ Jr; a Altria Client Services LLC , Richmond , VA , USA.
Pokaż więcej
Źródło:
Inhalation toxicology [Inhal Toxicol] 2018 Nov - Dec; Vol. 30 (13-14), pp. 553-567. Date of Electronic Publication: 2019 Mar 08.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Electronic Nicotine Delivery Systems*
Respiratory System/*drug effects
Smoke/*adverse effects
Tobacco Products/*adverse effects
Administration, Inhalation ; Aerosols ; Animals ; Bronchoalveolar Lavage Fluid/chemistry ; Bronchoalveolar Lavage Fluid/cytology ; Carboxyhemoglobin/analysis ; Female ; Gene Expression Profiling ; Mice, Inbred C57BL ; Respiratory Function Tests ; Respiratory Physiological Phenomena/drug effects ; Respiratory System/metabolism ; Respiratory System/pathology
Czasopismo naukowe
Tytuł:
A lower impact of an acute exposure to electronic cigarette aerosols than to cigarette smoke in human organotypic buccal and small airway cultures was demonstrated using systems toxicology assessment.
Autorzy:
Iskandar, Anita R.
Zanetti, Filippo
Kondylis, Athanasios
Martin, Florian
Leroy, Patrice
Majeed, Shoaib
Steiner, Sandro
Xiang, Yang
Ortega Torres, Laura
Trivedi, Keyur
Guedj, Emmanuel
Merg, Celine
Frentzel, Stefan
Ivanov, Nikolai V.
Doshi, Utkarsh
Lee, Kyeonghee Monica
McKinney, Willie J.
Peitsch, Manuel C.
Hoeng, Julia
McKinney, Willie J Jr
Pokaż więcej
Źródło:
Internal & Emergency Medicine; Sep2019, Vol. 14 Issue 6, p863-883, 21p
Czasopismo naukowe
Tytuł:
Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH™ technology.
Autorzy:
Iskandar, Anita R. (AUTHOR)
Zanetti, Filippo (AUTHOR)
Marescotti, Diego (AUTHOR)
Titz, Bjorn (AUTHOR)
Sewer, Alain (AUTHOR)
Kondylis, Athanasios (AUTHOR)
Leroy, Patrice (AUTHOR)
Belcastro, Vincenzo (AUTHOR)
Torres, Laura Ortega (AUTHOR)
Acali, Stefano (AUTHOR)
Majeed, Shoaib (AUTHOR)
Steiner, Sandro (AUTHOR)
Trivedi, Keyur (AUTHOR)
Guedj, Emmanuel (AUTHOR)
Merg, Celine (AUTHOR)
Schneider, Thomas (AUTHOR)
Frentzel, Stefan (AUTHOR)
Martin, Florian (AUTHOR)
Ivanov, Nikolai V. (AUTHOR)
Peitsch, Manuel C. (AUTHOR)
Pokaż więcej
Źródło:
Archives of Toxicology. Nov2019, Vol. 93 Issue 11, p3229-3247. 19p. 2 Color Photographs, 1 Diagram, 4 Charts, 3 Graphs.
Czasopismo naukowe
Tytuł:
The reduction of DSS-induced colitis severity in mice exposed to cigarette smoke is linked to immune modulation and microbial shifts.
Autorzy:
Lo Sasso G; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Phillips BW; PMI R&D, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore.
Sewer A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Battey JND; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Kondylis A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Talikka M; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Titz B; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Guedj E; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Peric D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Bornand D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Dulize R; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Merg C; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Corciulo M; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Ouadi S; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Yanuar R; PMI R&D, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore.
Tung CK; PMI R&D, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore.
Ivanov NV; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Peitsch MC; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
Hoeng J; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 02; Vol. 10 (1), pp. 3829. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis/*immunology
Colitis/*microbiology
Dextran Sulfate/*pharmacology
Smoke/*adverse effects
Tobacco Products/*adverse effects
Animals ; Colitis/chemically induced ; Male ; Mice ; Mice, Inbred C57BL ; Microbiota/drug effects
Czasopismo naukowe
Tytuł:
Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis
Autorzy:
Ruiz Castro, Pedro A.
Kogel, Ulrike
Lo Sasso, Giuseppe
Phillips, Blaine W.
Sewer, Alain
Titz, Bjorn
Garcia, Llenalia
Kondylis, Athanasios
Guedj, Emmanuel
Peric, Dariusz
Bornand, David
Dulize, Remi
Merg, Celine
Corciulo, Maica
Ivanov, Nikolai V.
Peitsch, Manuel C.
Hoeng, Julia
Pokaż więcej
Źródło:
Journal of Inflammation. 17(1)
Czasopismo naukowe
Tytuł:
Profiling of a Natural Alkaloid, Anatabine, in Rodents: Pharmacokinetics and Anti-Inflammatory Efficacy.
Autorzy:
Xia, Wenhao
Kolli, Aditya Reddy
Koshibu, Kyoko
Martin, Florian
Kondylis, Athanasios
Kuczaj, Arkadiusz
Tan, Wei Teck
Yeo, Ying Shan
Tan, Glenda
Teng, Charles
Woon, Kaing
Schneider, Thomas
Talikka, Marja
Phillips, Blaine W.
Vanscheeuwijck, Patrick
Peitsch, Manuel C.
Hoeng, Julia
Pokaż więcej
Źródło:
Journal of Natural Products; 4/23/2021, Vol. 84 Issue 4, p1012-1021, 10p
Czasopismo naukowe
Tytuł:
Blood and urine multi-omics analysis of the impact of e-vaping, smoking, and cessation: from exposome to molecular responses.
Autorzy:
Poussin C; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Titz B; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Xiang Y; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. .
Baglia L; University of Rochester Medical Center, Rochester, NY, USA.
Berg R; University of Rochester Medical Center, Rochester, NY, USA.
Bornand D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Choukrallah MA; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Curran T; University of Rochester Medical Center, Rochester, NY, USA.
Dijon S; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Dossin E; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Dulize R; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Etter D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Fatarova M; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Medlin LF; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Haiduc A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Kishazi E; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Kolli AR; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Kondylis A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Kottelat E; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Laszlo C; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Lavrynenko O; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Eb-Levadoux Y; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Nury C; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Peric D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Rizza M; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Schneider T; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Guedj E; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Calvino F; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Sierro N; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Guy P; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. .
Ivanov NV; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. .
Picavet P; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Spinelli S; University of Rochester Medical Center, Rochester, NY, USA.
Hoeng J; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Peitsch MC; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 21; Vol. 14 (1), pp. 4286. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Vaping*
Smoking Cessation*
Exposome*
Tobacco Products*
Electronic Nicotine Delivery Systems*
Humans ; Cross-Sectional Studies ; Multiomics
Czasopismo naukowe
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies